butaprost

Known as: 15-deoxy-16-hydroxy-17-cyclobutylprostaglandin E1 methyl ester, Cyclopentaneheptanoic acid, 3-hydroxy-2-(4-hydroxy-4-(1-propylcyclobutyl)-1-butenyl)-5-oxo-, methyl ester, (1R-(1alpha,2beta(1E,4R*),3alpha))-, DOH-CB-PGE1 
 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Alprostadil
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus.
In the kidney, the actions of vasopressin on its type-2 receptor (V2R) induce increased water reabsorption alongside… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
Prevalence of associated injuries of spinal trauma and their effect on medical utilization among hospitalized adult subjects – a nationwide data-based study
BACKGROUND This study was wanted to investigate the prevalence of concomitant injuries among hospitalized acute spinal trauma… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2006
2006
The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey.
PURPOSE To investigate the ocular hypotensive effect of the prostanoid EP2 receptor agonist butaprost and to establish its… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP.
Prostaglandin E(2) is a potent lipid mediator of inflammation that effects changes in cell functions through ligation of four… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Prostaglandin E(2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts.
The p38 MAPK mediates transcriptional and post-transcriptional control of cyclooxygenase-2 (COX-2) mRNA following interleukin-1… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells.
1. Eight types and subtypes of the mouse prostanoid receptor, the prostaglandin D (DP) receptor, the prostaglandin F (FP… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Roles of prostaglandin E-receptor subtypes in gastric and duodenal bicarbonate secretion in rats.
BACKGROUND & AIMS Receptors activated by prostaglandin (PG) E2 are pharmacologically subdivided into four subtypes (EP1-EP4). The… (More)
Is this relevant?
1995
1995
The mouse prostaglandin E receptor EP2 subtype: cloning, expression, and northern blot analysis.
A functional cDNA clone for the mouse prostaglandin (PG) E receptor EP2 subtype was isolated from a mouse cDNA library. The mouse… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
A cDNA that when expressed has the binding and functional characteristics of the pharmacologically defined EP2 prostaglandin (PG… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype.
A functional cDNA clone coding for the human prostaglandin E receptor EP1 subtype has been isolated from a human erythroleukemia… (More)
Is this relevant?